367 related articles for article (PubMed ID: 10351140)
1. Intravenous immunoglobulin G and anti-D as therapeutic interventions in immune thrombocytopenic purpura.
Blanchette V; Carcao M
Transfus Sci; 1998 Sep; 19(3):279-88. PubMed ID: 10351140
[TBL] [Abstract][Full Text] [Related]
2. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.
Blanchette V; Imbach P; Andrew M; Adams M; McMillan J; Wang E; Milner R; Ali K; Barnard D; Bernstein M
Lancet; 1994 Sep; 344(8924):703-7. PubMed ID: 7915773
[TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin and anti-D in idiopathic thrombocytopenic purpura (ITP): mechanisms of action.
Lazarus AH; Freedman J; Semple JW
Transfus Sci; 1998 Sep; 19(3):289-94. PubMed ID: 10351141
[TBL] [Abstract][Full Text] [Related]
4. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T
J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658
[TBL] [Abstract][Full Text] [Related]
6. Idiopathic thrombocytopenic purpura (ITP): immunomodulation by intravenous immunoglobulin (IVIg).
Imbach P; Morell A
Int Rev Immunol; 1989; 5(2):181-8. PubMed ID: 8691051
[TBL] [Abstract][Full Text] [Related]
7. Treatment of immune thrombocytopenic purpura in children : current concepts.
Shad AT; Gonzalez CE; Sandler SG
Paediatr Drugs; 2005; 7(5):325-36. PubMed ID: 16220997
[TBL] [Abstract][Full Text] [Related]
8. Treatment of childhood acute immune thrombocytopenic purpura with anti-D immune globulin or pooled immune globulin.
Tarantino MD; Madden RM; Fennewald DL; Patel CC; Bertolone SJ
J Pediatr; 1999 Jan; 134(1):21-6. PubMed ID: 9880444
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology.
George JN; Woolf SH; Raskob GE; Wasser JS; Aledort LM; Ballem PJ; Blanchette VS; Bussel JB; Cines DB; Kelton JG; Lichtin AE; McMillan R; Okerbloom JA; Regan DH; Warrier I
Blood; 1996 Jul; 88(1):3-40. PubMed ID: 8704187
[No Abstract] [Full Text] [Related]
10. Immune thrombocytopenic purpura ITP.
Imbach P; Kühne T
Vox Sang; 1998; 74 Suppl 2():309-14. PubMed ID: 9704461
[TBL] [Abstract][Full Text] [Related]
11. Role of intravenous immunoglobulin G in autoimmune hematologic disorders.
Blanchette VS; Kirby MA; Turner C
Semin Hematol; 1992 Jul; 29(3 Suppl 2):72-82. PubMed ID: 1509297
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute immune thrombocytopenic purpura.
Tarantino MD; Goldsmith G
Semin Hematol; 1998 Jan; 35(1 Suppl 1):28-35. PubMed ID: 9523747
[TBL] [Abstract][Full Text] [Related]
13. Management of immune thrombocytopenic purpura in children: potential role of novel agents.
Bredlau AL; Semple JW; Segel GB
Paediatr Drugs; 2011 Aug; 13(4):213-23. PubMed ID: 21692546
[TBL] [Abstract][Full Text] [Related]
14. Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms.
Cooper N; Heddle NM; Haas M; Reid ME; Lesser ML; Fleit HB; Woloski BM; Bussel JB
Br J Haematol; 2004 Feb; 124(4):511-8. PubMed ID: 14984503
[TBL] [Abstract][Full Text] [Related]
15. A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP).
O'Brien SH; Ritchey AK; Smith KJ
Pediatr Blood Cancer; 2007 Feb; 48(2):173-80. PubMed ID: 16550529
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immune globulin versus intravenous anti-D immune globulin for the treatment of acute immune thrombocytopenic purpura.
Shahgholi E; Vosough P; Sotoudeh K; Arjomandi K; Ansari S; Salehi S; Faranoush M; Ehsani MA
Indian J Pediatr; 2008 Dec; 75(12):1231-5. PubMed ID: 19190878
[TBL] [Abstract][Full Text] [Related]
17. Management of chronic immune thrombocytopenic purpura in children and adults.
Blanchette V; Freedman J; Garvey B
Semin Hematol; 1998 Jan; 35(1 Suppl 1):36-51. PubMed ID: 9523748
[TBL] [Abstract][Full Text] [Related]
18. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura.
Blanchette VS; Luke B; Andrew M; Sommerville-Nielsen S; Barnard D; de Veber B; Gent M
J Pediatr; 1993 Dec; 123(6):989-95. PubMed ID: 8229536
[TBL] [Abstract][Full Text] [Related]
19. Management of chronic autoimmune thrombocytopenic purpura (ITP) in adults.
Garvey B
Transfus Sci; 1998 Sep; 19(3):269-77. PubMed ID: 10351139
[TBL] [Abstract][Full Text] [Related]
20. Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia.
Barsam SJ; Psaila B; Forestier M; Page LK; Sloane PA; Geyer JT; Villarica GO; Ruisi MM; Gernsheimer TB; Beer JH; Bussel JB
Blood; 2011 May; 117(21):5723-32. PubMed ID: 21389318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
